newsfilter
← Latest News
GlobeNewswire·

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that detailed re